{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:03:34Z","timestamp":1786979014395,"version":"build-2736575974"},"publisher-location":"Cham","reference-count":169,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319956923","type":"print"},{"value":"9783319956930","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-95693-0_3","type":"book-chapter","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T06:42:40Z","timestamp":1537252960000},"page":"41-65","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Inflammation and Prostate Cancer"],"prefix":"10.1007","author":[{"given":"Ashutosh K.","family":"Tewari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Stockert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini S.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh K.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irtaza","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,19]]},"reference":[{"issue":"2","key":"3_CR1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc2067","volume":"7","author":"Adriana Albini","year":"2007","unstructured":"Albini A, Sporn MB (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7(2)","journal-title":"Nature Reviews Cancer"},{"issue":"6 Pt 1","key":"3_CR2","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1097\/01.ju.0000085381.20139.b6","volume":"170","author":"ML Gonzalgo","year":"2003","unstructured":"Gonzalgo ML, Isaacs WB (2003) Molecular pathways to prostate cancer. J Urol 170(6 Pt 1):2444\u20132452","journal-title":"J Urol"},{"issue":"6","key":"3_CR3","first-page":"1398","volume":"63","author":"GA Pihan","year":"2003","unstructured":"Pihan GA et al (2003) Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 63(6):1398\u20131404","journal-title":"Cancer Res"},{"issue":"23","key":"3_CR4","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/jnci\/djm260","volume":"99","author":"L Savage","year":"2007","unstructured":"Savage L (2007) Unreported VA data may affect SEER research, Cancer surveillance, and statistics gathering. JNCI J. Natl. Cancer Inst 99(23):1744\u20131752","journal-title":"JNCI J. Natl. Cancer Inst"},{"issue":"3","key":"3_CR5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdl498","volume":"18","author":"J Ferlay","year":"2006","unstructured":"Ferlay J et\u00a0al (2006) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18(3):581\u2013592","journal-title":"Ann Oncol"},{"issue":"1075","key":"3_CR6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/bmj.2.1075.198","volume":"2","author":"R Virchow","year":"1881","unstructured":"Virchow R (1881) An address on the value of pathological experiments. Br Med J 2(1075):198\u2013203","journal-title":"Br Med J"},{"issue":"11","key":"3_CR7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav E et al (2013) Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13(11):759\u2013771","journal-title":"Nat Rev Cancer"},{"key":"3_CR8","unstructured":"Bishayee A (2014) The Inflammation and Liver Cancer, in Advances in Experimental Medicine and Biology. Springer Nature, pp 401\u2013435"},{"issue":"1","key":"3_CR9","first-page":"3","volume":"1","author":"KS Sfanos","year":"2013","unstructured":"Sfanos KS, Isaacs WB, De Marzo AM (2013) Infections and inflammation in prostate cancer. Am J Clin Exp Urol 1(1):3\u201311","journal-title":"Am J Clin Exp Urol"},{"issue":"5","key":"3_CR10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1055-9965.EPI-13-1126","volume":"23","author":"B Gurel","year":"2014","unstructured":"Gurel B et al (2014) Chronic inflammation in benign prostate tissue is associated with high-grade prostate Cancer in the placebo arm of the prostate Cancer prevention trial. Cancer Epidemiol Biomark Prev 23(5):847\u2013856","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"7203","key":"3_CR11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A et al (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444","journal-title":"Nature"},{"issue":"1","key":"3_CR12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","volume":"60","author":"KS Sfanos","year":"2011","unstructured":"Sfanos KS, De Marzo AM (2011) Prostate cancer and inflammation: the evidence. Histopathology 60(1):199\u2013215","journal-title":"Histopathology"},{"issue":"1","key":"3_CR13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/107327480701400111","volume":"14","author":"J Lee","year":"2007","unstructured":"Lee J et\u00a0al (2007) Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. Cancer Control 14(1):78\u201385","journal-title":"Cancer Control"},{"issue":"1","key":"3_CR14","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00000658-193501000-00064","volume":"101","author":"PS Pelouze","year":"1935","unstructured":"Pelouze PS (1935) Obscure pseudomembranous Trigonitis: Trigonitis Areata Alba. Ann Surg 101(1):594\u2013598","journal-title":"Ann Surg"},{"key":"3_CR15","first-page":"550","volume-title":"Etiology of prostate. Prostatic diseases","author":"W Bushman","year":"2000","unstructured":"Bushman W (2000) In: Lepor H (ed) Etiology of prostate. Prostatic diseases. W B Saunders Company, Philadelphia, pp 550\u2013557"},{"issue":"4","key":"3_CR16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/pros.10157","volume":"53","author":"A Zambrano","year":"2002","unstructured":"Zambrano A et al (2002) Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 53(4):263\u2013276","journal-title":"Prostate"},{"issue":"3","key":"3_CR17","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/01.ju.0000080263.46164.97","volume":"170","author":"M Samanta","year":"2003","unstructured":"Samanta M et al (2003) High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 170(3):998\u20131002","journal-title":"J Urol"},{"key":"3_CR18","doi-asserted-by":"crossref","unstructured":"Strasner A, Karin M (2015) Immune infiltration and prostate Cancer. Front Oncol 5","DOI":"10.3389\/fonc.2015.00128"},{"issue":"3","key":"3_CR19","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0022-5347(01)66357-2","volume":"155","author":"BE Persson","year":"1996","unstructured":"Persson BE, Ronquist G (1996) Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion. J Urol 155(3):958\u2013960","journal-title":"J Urol"},{"issue":"13","key":"3_CR20","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/jama.291.13.1578","volume":"291","author":"MF Leitzmann","year":"2004","unstructured":"Leitzmann MF et al (2004) Ejaculation frequency and subsequent risk of prostate cancer. JAMA 291(13):1578\u20131586","journal-title":"JAMA"},{"issue":"4","key":"3_CR21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1158\/1078-0432.CCR-14-2235","volume":"21","author":"AC Vidal","year":"2014","unstructured":"Vidal AC et al (2014) Aspirin, NSAIDs, and risk of prostate cancer: Results from the REDUCE study. Clin Cancer Res 21(4):756\u2013762","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3_CR22","first-page":"1306","volume":"60","author":"JL Masferrer","year":"2000","unstructured":"Masferrer JL et al (2000) Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60(5):1306\u20131311","journal-title":"Cancer Res"},{"issue":"4","key":"3_CR23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1517\/14740331003662620","volume":"9","author":"DM Boudreau","year":"2010","unstructured":"Boudreau DM, Yu O, Johnson J (2010) Statin use and cancer risk: a comprehensive review. Expert Opin Drug Saf 9(4):603\u2013621","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"3_CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/CVM-1-3-161","volume":"1","author":"GJ Blake","year":"2000","unstructured":"Blake GJ, Ridker PM (2000) Are statins anti-inflammatory? Curr Control Trials Cardiovasc Med 1(3):161\u2013165","journal-title":"Curr Control Trials Cardiovasc Med"},{"issue":"6","key":"3_CR25","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0002-9440(10)65517-4","volume":"155","author":"AM Marzo De","year":"1999","unstructured":"De Marzo AM et al (1999) Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155(6):1985\u20131992","journal-title":"Am J Pathol"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1749-6632.2002.tb04108.x","volume":"963","author":"R Montironi","year":"2002","unstructured":"Montironi R, Mazzucchelli R, Scarpelli M (2002) Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention. Ann N Y Acad Sci 963:169\u2013184","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"3_CR27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/canjclin.29.2.115","volume":"29","author":"AR Rich","year":"1979","unstructured":"Rich AR (1979) Classics in oncology. On the frequency of occurrence of occult carcinoma of the prostate: Arnold rice Rich, M.D., Journal of urology 33:3, 1935. CA Cancer J Clin 29(2):115\u2013119","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"3_CR28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/00000478-198812000-00001","volume":"12","author":"JE McNeal","year":"1988","unstructured":"McNeal JE et al (1988) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12(12):897\u2013906","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"3_CR29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0002-9440(10)63452-9","volume":"163","author":"M Nakayama","year":"2003","unstructured":"Nakayama M et al (2003) Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol 163(3):923\u2013933","journal-title":"Am J Pathol"},{"issue":"22","key":"3_CR30","doi-asserted-by":"crossref","first-page":"10683","DOI":"10.1158\/0008-5472.CAN-06-0963","volume":"66","author":"CR Bethel","year":"2006","unstructured":"Bethel CR et al (2006) Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with Gleason score and chromosome 8p deletion. Cancer Res 66(22):10683\u201310690","journal-title":"Cancer Res"},{"issue":"5","key":"3_CR31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-9525(02)02683-5","volume":"18","author":"C Abate-Shen","year":"2002","unstructured":"Abate-Shen C, Shen MM (2002) Mouse models of prostate carcinogenesis. Trends Genet 18(5):S1\u2013S5","journal-title":"Trends Genet"},{"issue":"6917","key":"3_CR32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860\u2013867","journal-title":"Nature"},{"issue":"11","key":"3_CR33","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1600-0463.2012.02924.x","volume":"120","author":"A Flammiger","year":"2012","unstructured":"Flammiger A et al (2012) Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer. APMIS 120(11):901\u2013908","journal-title":"APMIS"},{"issue":"4","key":"3_CR34","first-page":"171","volume":"4","author":"GE Steiner","year":"2002","unstructured":"Steiner GE et al (2002) The picture of the prostatic lymphokine network is becoming increasingly complex. Rev Urol 4(4):171\u2013177","journal-title":"Rev Urol"},{"issue":"3","key":"3_CR35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pros.10238","volume":"56","author":"GE Steiner","year":"2003","unstructured":"Steiner GE et al (2003) Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 56(3):171\u2013182","journal-title":"Prostate"},{"issue":"8","key":"3_CR36","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.LAB.0000081388.40145.65","volume":"83","author":"GE Steiner","year":"2003","unstructured":"Steiner GE et al (2003) Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab Investig 83(8):1131\u20131146","journal-title":"Lab Investig"},{"issue":"10","key":"3_CR37","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.4049\/jimmunol.177.10.7398","volume":"177","author":"AM Miller","year":"2006","unstructured":"Miller AM et al (2006) CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients. J Immunol 177(10):7398\u20137405","journal-title":"J Immunol"},{"key":"3_CR38","unstructured":"Sfanos KS, Hempel HA, De Marzo AM (2014) The role of inflammation in prostate cancer, in advances in experimental medicine and biology. Springer Nature, pp 153\u2013181"},{"key":"3_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/486798","volume":"2014","author":"M Lanciotti","year":"2014","unstructured":"Lanciotti M et al (2014) The role of M1 and M2 macrophages in prostate Cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy. Biomed Res Int 2014:1\u20136","journal-title":"Biomed Res Int"},{"issue":"2","key":"3_CR40","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2353\/ajpath.2010.100070","volume":"177","author":"A Johansson","year":"2010","unstructured":"Johansson A et al (2010) Mast cells are novel independent prognostic markers in prostate Cancer and represent a target for therapy. Am J Pathol 177(2):1031\u20131041","journal-title":"Am J Pathol"},{"issue":"9","key":"3_CR41","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/pros.20948","volume":"69","author":"A Fleischmann","year":"2009","unstructured":"Fleischmann A et al (2009) Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis. Prostate 69(9):976\u2013981","journal-title":"Prostate"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/sj.bjc.6603962","volume":"97","author":"N Nonomura","year":"2007","unstructured":"Nonomura N et al (2007) Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. Br J Cancer 97:952\u2013956","journal-title":"Br J Cancer"},{"issue":"1","key":"3_CR43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10555-011-9286-z","volume":"30","author":"K Khazaie","year":"2011","unstructured":"Khazaie K et al (2011) The significant role of mast cells in cancer. Cancer Metastasis Rev 30(1):45\u201360","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"3_CR44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2559.2008.03058.x","volume":"53","author":"E Richardsen","year":"2008","unstructured":"Richardsen E et al (2008) The prognostic impact of M-CSF, CSF-1 receptor, CD68 and CD3 in prostatic carcinoma. Histopathology 53(1):30\u201338","journal-title":"Histopathology"},{"issue":"3","key":"3_CR45","first-page":"149","volume":"6","author":"C Lindahl","year":"2009","unstructured":"Lindahl C et al (2009) Increased levels of macrophage-secreted cathepsin S during prostate cancer progression in TRAMP mice and patients. Cancer Genomics Proteomics 6(3):149\u2013159","journal-title":"Cancer Genomics Proteomics"},{"issue":"12","key":"3_CR46","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/onc.2012.166","volume":"32","author":"MK Herroon","year":"2012","unstructured":"Herroon MK et al (2012) Macrophage cathepsin K promotes prostate tumor progression in bone. Oncogene 32(12):1580\u20131593","journal-title":"Oncogene"},{"issue":"11","key":"3_CR47","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1158\/1078-0432.CCR-07-5164","volume":"14","author":"KS Sfanos","year":"2008","unstructured":"Sfanos KS et al (2008) Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res 14(11):3254\u20133261","journal-title":"Clin Cancer Res"},{"issue":"7286","key":"3_CR48","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature08782","volume":"464","author":"M Ammirante","year":"2010","unstructured":"Ammirante M et al (2010) B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464(7286):302\u2013305","journal-title":"Nature"},{"issue":"5291","key":"3_CR49","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1126\/science.274.5291.1371","volume":"274","author":"JR Smith","year":"1996","unstructured":"Smith JR et al (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274(5291):1371\u20131374","journal-title":"Science"},{"issue":"2","key":"3_CR50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng994","volume":"32","author":"J Xu","year":"2002","unstructured":"Xu J et\u00a0al (2002) Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet 32(2):321\u2013325","journal-title":"Nat Genet"},{"issue":"8","key":"3_CR51","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1158\/0008-5472.CAN-03-3280","volume":"64","author":"SL Zheng","year":"2004","unstructured":"Zheng SL et al (2004) Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer prostate in Sweden study. Cancer Res 64(8):2918\u20132922","journal-title":"Cancer Res"},{"issue":"16","key":"3_CR52","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/jnci\/djh227","volume":"96","author":"F Lindmark","year":"2004","unstructured":"Lindmark F et al (2004) H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J Natl Cancer Inst 96(16):1248\u20131254","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"3_CR53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.bjc.6602729","volume":"93","author":"F Lindmark","year":"2005","unstructured":"Lindmark F et al (2005) Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. Br J Cancer 93(4):493\u2013497","journal-title":"Br J Cancer"},{"key":"3_CR54","unstructured":"Khanna RD et al (2014) Inflammation, free radical damage, oxidative stress and cancer. Microinflammation 1:109. \nhttps:\/\/doi.org\/10.4172\/2381-8727.1000109"},{"issue":"1","key":"3_CR55","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0192623309356453","volume":"38","author":"JE Klaunig","year":"2009","unstructured":"Klaunig JE, Kamendulis LM, Hocevar BA (2009) Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 38(1):96\u2013109","journal-title":"Toxicol Pathol"},{"issue":"5","key":"3_CR56","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10715761003667554","volume":"44","author":"G-Y Liou","year":"2010","unstructured":"Liou G-Y, Storz P (2010) Reactive oxygen species in cancer. Free Radic Res 44(5):479\u2013496","journal-title":"Free Radic Res"},{"issue":"11","key":"3_CR57","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/ijc.23192","volume":"121","author":"A Federico","year":"2007","unstructured":"Federico A et al (2007) Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121(11):2381\u20132386","journal-title":"Int J Cancer"},{"issue":"1","key":"3_CR58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgn250","volume":"30","author":"S Maynard","year":"2008","unstructured":"Maynard S et al (2008) Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 30(1):2\u201310","journal-title":"Carcinogenesis"},{"issue":"3","key":"3_CR59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0165-1110(88)90004-8","volume":"195","author":"JL Bos","year":"1988","unstructured":"Bos JL (1988) The ras gene family and human carcinogenesis. Mutation Research\/Reviews in Genetic Toxicology 195(3):255\u2013271","journal-title":"Mutation Research\/Reviews in Genetic Toxicology"},{"issue":"4929","key":"3_CR60","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.2554494","volume":"246","author":"T Takahashi","year":"1989","unstructured":"Takahashi T et al (1989) p53: a frequent target for genetic abnormalities in lung cancer. Science 246(4929):491\u2013494","journal-title":"Science"},{"issue":"1","key":"3_CR61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.canlet.2008.02.026","volume":"266","author":"R Franco","year":"2008","unstructured":"Franco R et al (2008) Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 266(1):6\u201311","journal-title":"Cancer Lett"},{"issue":"3","key":"3_CR62","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/0008-5472.CAN-06-3123","volume":"67","author":"V Valinluck","year":"2007","unstructured":"Valinluck V, Sowers LC (2007) Endogenous cytosine damage products Alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res 67(3):946\u2013950","journal-title":"Cancer Res"},{"issue":"8","key":"3_CR63","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/07357900701561131","volume":"25","author":"C Long","year":"2007","unstructured":"Long C et al (2007) Promoter Hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma. Cancer Investig 25(8):685\u2013690","journal-title":"Cancer Investig"},{"issue":"23","key":"3_CR64","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1128\/MCB.23.23.8429-8439.2003","volume":"23","author":"Y Akiyama","year":"2003","unstructured":"Akiyama Y et al (2003) GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric Cancer. Mol Cell Biol 23(23):8429\u20138439","journal-title":"Mol Cell Biol"},{"issue":"1","key":"3_CR65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","volume":"31","author":"S Sharma","year":"2009","unstructured":"Sharma S, Kelly TK, Jones PA (2009) Epigenetics in cancer. Carcinogenesis 31(1):27\u201336","journal-title":"Carcinogenesis"},{"issue":"8","key":"3_CR66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/ars.2007.1957","volume":"10","author":"D Trachootham","year":"2008","unstructured":"Trachootham D et al (2008) Redox regulation of cell survival. Antioxid Redox Signal 10(8):1343\u20131374","journal-title":"Antioxid Redox Signal"},{"issue":"31","key":"3_CR67","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/onc.2008.79","volume":"27","author":"DA Frohlich","year":"2008","unstructured":"Frohlich DA et al (2008) The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis. Oncogene 27(31):4353\u20134362","journal-title":"Oncogene"},{"issue":"5","key":"3_CR68","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.ju.0000142058.99614.ff","volume":"172","author":"WG Nelson","year":"2004","unstructured":"Nelson WG et al (2004) The role of inflammation in the pathogenesis of prostate cancer. J Urol 172(5):S6\u2013S12","journal-title":"J Urol"},{"issue":"6","key":"3_CR69","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/01.ju.0000127728.71350.36","volume":"171","author":"M Zhou","year":"2004","unstructured":"Zhou M et al (2004) Quantitative GSTP1 methylation levels correlate with Gleason grade and tumor volume in prostate needle biopsies. J Urol 171(6):2195\u20132198","journal-title":"J Urol"},{"issue":"2","key":"3_CR70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2008.12.011","volume":"282","author":"L Khandrika","year":"2009","unstructured":"Khandrika L et al (2009) Oxidative stress in prostate cancer. Cancer Lett 282(2):125\u2013136","journal-title":"Cancer Lett"},{"issue":"2","key":"3_CR71","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1073\/pnas.022630199","volume":"99","author":"JL Arbiser","year":"2002","unstructured":"Arbiser JL et al (2002) Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci 99(2):715\u2013720","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"3_CR72","first-page":"C353","volume":"285","author":"SS Brar","year":"2003","unstructured":"Brar SS et al (2003) NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. AJP: Cell Physiol 285(2):C353\u2013C369","journal-title":"AJP: Cell Physiol"},{"issue":"6","key":"3_CR73","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/S0002-9440(10)63606-1","volume":"163","author":"NNC Tam","year":"2003","unstructured":"Tam NNC et al (2003) Androgenic regulation of oxidative stress in the rat prostate. Am J Pathol 163(6):2513\u20132522","journal-title":"Am J Pathol"},{"issue":"1","key":"3_CR74","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.canlet.2007.11.015","volume":"261","author":"S Pathak","year":"2008","unstructured":"Pathak S et al (2008) Androgen manipulation alters oxidative DNA adduct levels in androgen-sensitive prostate cancer cells grown in vitro and in vivo. Cancer Lett 261(1):74\u201383","journal-title":"Cancer Lett"},{"issue":"4","key":"3_CR75","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/01.ju.0000116617.32728.ca","volume":"171","author":"H Miyake","year":"2004","unstructured":"Miyake H et al (2004) Oxidative DNA damage in patients with prostate cancer and its response to treatment. J Urol 171(4):1533\u20131536","journal-title":"J Urol"},{"issue":"11","key":"3_CR76","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00262-005-0702-5","volume":"54","author":"KE Visser de","year":"2005","unstructured":"de Visser KE, Coussens LM (2005) The interplay between innate and adaptive immunity regulates cancer development. Cancer Immunol Immunother 54(11):1143\u20131152","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"3_CR77","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/1541-7786.MCR-05-0261","volume":"4","author":"H Lu","year":"2006","unstructured":"Lu H (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4(4):221\u2013233","journal-title":"Mol Cancer Res"},{"issue":"6","key":"3_CR78","doi-asserted-by":"crossref","first-page":"F23","DOI":"10.1084\/jem.193.6.F23","volume":"193","author":"LM Coussens","year":"2001","unstructured":"Coussens LM, Werb Z (2001) Inflammatory cells and Cancer. J Exp Med 193(6):F23\u2013F26","journal-title":"J Exp Med"},{"issue":"11","key":"3_CR79","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1038\/sj.bjc.6601705","volume":"90","author":"EY Lin","year":"2004","unstructured":"Lin EY, Pollard JW (2004) Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 90(11):2053\u20132058","journal-title":"Br J Cancer"},{"issue":"9","key":"3_CR80","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/1521-4141(200209)32:9<2393::AID-IMMU2393>3.0.CO;2-4","volume":"32","author":"MJ Grimshaw","year":"2002","unstructured":"Grimshaw MJ, Wilson JL, Balkwill FR (2002) Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors. Eur J Immunol 32(9):2393\u20132400","journal-title":"Eur J Immunol"},{"issue":"1","key":"3_CR81","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","volume":"4","author":"JW Pollard","year":"2004","unstructured":"Pollard JW (2004) Opinion: tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4(1):71\u201378","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3_CR82","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.gde.2009.11.004","volume":"20","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Karin M (2010) Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev 20(1):65\u201371","journal-title":"Curr Opin Genet Dev"},{"issue":"10","key":"3_CR83","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","volume":"12","author":"SM Crusz","year":"2015","unstructured":"Crusz SM, Balkwill FR (2015) Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol 12(10):584\u2013596","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"3_CR84","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.immuni.2009.06.004","volume":"30","author":"R Medzhitov","year":"2009","unstructured":"Medzhitov R (2009) Approaching the asymptote: 20 years later. Immunity 30(6):766\u2013775","journal-title":"Immunity"},{"issue":"2","key":"3_CR85","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10(2):417\u2013426","journal-title":"Mol Cell"},{"key":"3_CR86","first-page":"1","volume-title":"Inflammasomes and inflammation, in cancer and inflammation mechanisms : chemical, biological, and clinical aspects","author":"KW Chen","year":"2014","unstructured":"Chen KW et al (2014) In: Hiraku YU, Kawanishi SO, Oshima H (eds) Inflammasomes and inflammation, in cancer and inflammation mechanisms : chemical, biological, and clinical aspects, p 1 online resource (409 pages)"},{"issue":"5297","key":"3_CR87","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.275.5297.206","volume":"275","author":"Y Gu","year":"1997","unstructured":"Gu Y et al (1997) Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275(5297):206\u2013209","journal-title":"Science"},{"issue":"2","key":"3_CR88","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder K et al (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75(2):163\u2013189","journal-title":"J Leukoc Biol"},{"issue":"1","key":"3_CR89","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","volume":"31","author":"C Scheede-Bergdahl","year":"2012","unstructured":"Scheede-Bergdahl C et al (2012) Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia? Clin Nutr 31(1):85\u201388","journal-title":"Clin Nutr"},{"issue":"7101","key":"3_CR90","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature04808","volume":"442","author":"JL Langowski","year":"2006","unstructured":"Langowski JL et al (2006) IL-23 promotes tumour incidence and growth. Nature 442(7101):461\u2013465","journal-title":"Nature"},{"issue":"20","key":"3_CR91","doi-asserted-by":"crossref","first-page":"10019","DOI":"10.1158\/0008-5472.CAN-07-2354","volume":"67","author":"SK Bunt","year":"2007","unstructured":"Bunt SK et al (2007) Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res 67(20):10019\u201310026","journal-title":"Cancer Res"},{"issue":"8","key":"3_CR92","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.4049\/jimmunol.1002046","volume":"185","author":"MH Zaki","year":"2010","unstructured":"Zaki MH et al (2010) IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol 185(8):4912\u20134920","journal-title":"J Immunol"},{"issue":"10","key":"3_CR93","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","volume":"15","author":"F Ghiringhelli","year":"2009","unstructured":"Ghiringhelli F et al (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 15(10):1170\u20131178","journal-title":"Nat Med"},{"key":"3_CR94","first-page":"1","volume-title":"MicroRNAs and Inflammation-related cancer, in cancer and inflammation mechanisms : chemical, biological, and clinical aspects","author":"Z Gong","year":"2014","unstructured":"Gong Z et al (2014) In: Hiraku YU, Kawanishi SO, Oshima H (eds) MicroRNAs and Inflammation-related cancer, in cancer and inflammation mechanisms : chemical, biological, and clinical aspects, p 1 online resource (409 pages)"},{"issue":"6","key":"3_CR95","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/08830180903208303","volume":"28","author":"E Sonkoly","year":"2009","unstructured":"Sonkoly E, Pivarcsi A (2009) microRNAs in inflammation. Int Rev Immunol 28(6):535\u2013561","journal-title":"Int Rev Immunol"},{"issue":"1","key":"3_CR96","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/carcin\/bgp272","volume":"31","author":"AJ Schetter","year":"2010","unstructured":"Schetter AJ, Heegaard NH, Harris CC (2010) Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31(1):37\u201349","journal-title":"Carcinogenesis"},{"issue":"10","key":"3_CR97","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5(10):749\u2013759","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"3_CR98","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nrc2444","volume":"8","author":"C Murdoch","year":"2008","unstructured":"Murdoch C et al (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8(8):618\u2013631","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3_CR99","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood-2007-03-081133","volume":"110","author":"D Loffler","year":"2007","unstructured":"Loffler D et al (2007) Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110(4):1330\u20131333","journal-title":"Blood"},{"issue":"19","key":"3_CR100","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/sj.onc.1210083","volume":"26","author":"ML Si","year":"2007","unstructured":"Si ML et al (2007) miR-21-mediated tumor growth. Oncogene 26(19):2799\u20132803","journal-title":"Oncogene"},{"issue":"4","key":"3_CR101","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","volume":"139","author":"D Iliopoulos","year":"2009","unstructured":"Iliopoulos D, Hirsch HA, Struhl K (2009) An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139(4):693\u2013706","journal-title":"Cell"},{"issue":"3","key":"3_CR102","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/rna.4.3.5206","volume":"4","author":"N Motsch","year":"2007","unstructured":"Motsch N et al (2007) Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol 4(3):131\u2013137","journal-title":"RNA Biol"},{"issue":"41","key":"3_CR103","doi-asserted-by":"crossref","first-page":"16170","DOI":"10.1073\/pnas.0703942104","volume":"104","author":"M Gironella","year":"2007","unstructured":"Gironella M et al (2007) Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A 104(41):16170\u201316175","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3_CR104","first-page":"105","volume":"24","author":"J Pan","year":"2010","unstructured":"Pan J et\u00a0al (2010) Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. Oncol Rep 24(1):105\u2013112","journal-title":"Oncol Rep"},{"issue":"4","key":"3_CR105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.18632\/aging.100042","volume":"1","author":"D Bhaumik","year":"2009","unstructured":"Bhaumik D et al (2009) MicroRNAs miR-146a\/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY) 1(4):402\u2013411","journal-title":"Aging (Albany NY)"},{"issue":"16","key":"3_CR106","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/pros.22878","volume":"74","author":"Q Sun","year":"2014","unstructured":"Sun Q et al (2014) miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1. Prostate 74(16):1613\u20131621","journal-title":"Prostate"},{"issue":"7","key":"3_CR107","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1158\/1940-6207.CAPR-10-0333","volume":"4","author":"Y Hao","year":"2011","unstructured":"Hao Y et al (2011) Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev Res (Phila) 4(7):1073\u20131083","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5908","key":"3_CR108","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1165395","volume":"322","author":"S Varambally","year":"2008","unstructured":"Varambally S et al (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322(5908):1695\u20131699","journal-title":"Science"},{"issue":"1","key":"3_CR109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1535-7163.MCT-07-0573","volume":"7","author":"PE Blower","year":"2008","unstructured":"Blower PE et al (2008) MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 7(1):1\u20139","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"3_CR110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ijc.24782","volume":"126","author":"T Zheng","year":"2010","unstructured":"Zheng T et al (2010) Role of microRNA in anticancer drug resistance. Int J Cancer 126(1):2\u201310","journal-title":"Int J Cancer"},{"issue":"1","key":"3_CR111","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","volume":"4","author":"G Dranoff","year":"2004","unstructured":"Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4(1):11\u201322","journal-title":"Nat Rev Cancer"},{"key":"3_CR112","unstructured":"Vasto S et al (2012) Inflammation and cancer of the prostate, in prostate cancer: a comprehensive perspective. Springer Nature, pp 115\u2013122"},{"issue":"6","key":"3_CR113","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and Cancer. Cell 140(6):883\u2013899","journal-title":"Cell"},{"issue":"1","key":"3_CR114","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9440(10)64535-X","volume":"157","author":"D Giri","year":"2000","unstructured":"Giri D, Ittmann M (2000) Interleukin-1\u03b1 is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia. Am J Pathol 157(1):249\u2013255","journal-title":"Am J Pathol"},{"issue":"2","key":"3_CR115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/pros.10286","volume":"57","author":"P Furbert-Harris","year":"2003","unstructured":"Furbert-Harris P et al (2003) Inhibition of prostate cancer cell growth by activated eosinophils. Prostate 57(2):165\u2013175","journal-title":"Prostate"},{"issue":"6","key":"3_CR116","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/bju.12452","volume":"113","author":"DP Nguyen","year":"2014","unstructured":"Nguyen DP, Li J, Tewari AK (2014) Inflammation and prostate cancer: the role of interleukin 6 (IL-6). BJU Int 113(6):986\u2013992","journal-title":"BJU Int"},{"issue":"1\u20132","key":"3_CR117","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0303-7207(02)00263-0","volume":"197","author":"Z Culig","year":"2002","unstructured":"Culig Z, Bartsch G, Hobisch A (2002) Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth. Mol Cell Endocrinol 197(1\u20132):231\u2013238","journal-title":"Mol Cell Endocrinol"},{"issue":"24","key":"3_CR118","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.1128\/MCB.21.24.8471-8482.2001","volume":"21","author":"PD Deeble","year":"2001","unstructured":"Deeble PD et al (2001) Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells. Mol Cell Biol 21(24):8471\u20138482","journal-title":"Mol Cell Biol"},{"issue":"3","key":"3_CR119","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12307-011-0073-8","volume":"4","author":"JL Sottnik","year":"2011","unstructured":"Sottnik JL et al (2011) The PCa tumor microenvironment. Cancer Microenviron 4(3):283\u2013297","journal-title":"Cancer Microenviron"},{"issue":"14","key":"3_CR120","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1101\/gad.1549407","volume":"21","author":"B Ancrile","year":"2007","unstructured":"Ancrile B, Lim KH, Counter CM (2007) Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev 21(14):1714\u20131719","journal-title":"Genes Dev"},{"issue":"6333","key":"3_CR121","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/352345a0","volume":"352","author":"E Yonish-Rouach","year":"1991","unstructured":"Yonish-Rouach E et al (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352(6333):345\u2013347","journal-title":"Nature"},{"issue":"16","key":"3_CR122","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","volume":"41","author":"DR Hodge","year":"2005","unstructured":"Hodge DR, Hurt EM, Farrar WL (2005) The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 41(16):2502\u20132512","journal-title":"Eur J Cancer"},{"issue":"3","key":"3_CR123","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jcb.20477","volume":"95","author":"Z Culig","year":"2005","unstructured":"Culig Z et al (2005) Interleukin-6 regulation of prostate cancer cell growth. J Cell Biochem 95(3):497\u2013505","journal-title":"J Cell Biochem"},{"issue":"3","key":"3_CR124","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1365-2141.1998.00835.x","volume":"102","author":"HC Zaanen van","year":"1998","unstructured":"van Zaanen HC et al (1998) Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study. Br J Haematol 102(3):783\u2013790","journal-title":"Br J Haematol"},{"issue":"20","key":"3_CR125","first-page":"4633","volume":"55","author":"N Borsellino","year":"1995","unstructured":"Borsellino N, Belldegrun A, Bonavida B (1995) Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. Cancer Res 55(20):4633\u20134639","journal-title":"Cancer Res"},{"issue":"3","key":"3_CR126","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10637-012-9857-z","volume":"31","author":"G Hudes","year":"2013","unstructured":"Hudes G et al (2013) A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer. Investig New Drugs 31(3):669\u2013676","journal-title":"Investig New Drugs"},{"issue":"2","key":"3_CR127","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1359-6101(01)00020-X","volume":"13","author":"F Balkwill","year":"2002","unstructured":"Balkwill F (2002) Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 13(2):135\u2013141","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"3_CR128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni0302-221","volume":"3","author":"M Karin","year":"2002","unstructured":"Karin M, Lin A (2002) NF-\u03baB at the crossroads of life and death. Nat Immunol 3(3):221\u2013227","journal-title":"Nat Immunol"},{"issue":"2","key":"3_CR129","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bju.12488","volume":"114","author":"DP Nguyen","year":"2014","unstructured":"Nguyen DP et al (2014) Recent insights into NF-kappaB signalling pathways and the link between inflammation and prostate cancer. BJU Int 114(2):168\u2013176","journal-title":"BJU Int"},{"issue":"3","key":"3_CR130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pros.10082","volume":"52","author":"J Suh","year":"2002","unstructured":"Suh J et\u00a0al (2002) Mechanisms of constitutive NF-\u03baB activation in human prostate cancer cells. Prostate 52(3):183\u2013200","journal-title":"Prostate"},{"issue":"4","key":"3_CR131","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1593\/neo.04112","volume":"6","author":"S Shukla","year":"2004","unstructured":"Shukla S et al (2004) Nuclear factor-\u03baB\/p65 (Rel a) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia 6(4):390\u2013400","journal-title":"Neoplasia"},{"key":"3_CR132","unstructured":"Fuxe, J. and M.C.I. Karlsson, Epithelial\u2013Mesenchymal transition: a link between cancer and inflammation, in cancer and inflammation mechanisms : chemical, biological, and clinical aspects, Y. U. Hiraku, S. O. Kawanishi, and H. Oshima, Editors. p. 1 online resource (409 pages)"},{"issue":"2","key":"3_CR133","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ceb.2009.01.021","volume":"21","author":"CH Heldin","year":"2009","unstructured":"Heldin CH, Landstrom M, Moustakas A (2009) Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 21(2):166\u2013176","journal-title":"Curr Opin Cell Biol"},{"issue":"2","key":"3_CR134","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu J, Lamouille S, Derynck R (2009) TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19(2):156\u2013172","journal-title":"Cell Res"},{"issue":"3","key":"3_CR135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tibs.2009.10.002","volume":"35","author":"D Wu","year":"2010","unstructured":"Wu D, Pan W (2010) GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem Sci 35(3):161\u2013168","journal-title":"Trends Biochem Sci"},{"issue":"8","key":"3_CR136","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10585-007-9118-2","volume":"24","author":"JT Buijs","year":"2007","unstructured":"Buijs JT et al (2007) TGF-beta and BMP7 interactions in tumour progression and bone metastasis. Clin Exp Metastasis 24(8):609\u2013617","journal-title":"Clin Exp Metastasis"},{"issue":"12","key":"3_CR137","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.4161\/cc.9.12.12050","volume":"9","author":"J Fuxe","year":"2010","unstructured":"Fuxe J, Vincent T, Garcia A (2010) De Herreros, Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 9(12):2363\u20132374","journal-title":"Cell Cycle"},{"issue":"1","key":"3_CR138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016068","volume":"6","author":"MY Maitah","year":"2011","unstructured":"Maitah MY et al (2011) Up-regulation of sonic hedgehog contributes to TGF-beta1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One 6(1):e16068","journal-title":"PLoS One"},{"issue":"19","key":"3_CR139","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1101\/gad.10.19.2462","volume":"10","author":"M Oft","year":"1996","unstructured":"Oft M et al (1996) TGF-beta1 and ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 10(19):2462\u20132477","journal-title":"Genes Dev"},{"issue":"5","key":"3_CR140","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.emboj.7600069","volume":"23","author":"J Zavadil","year":"2004","unstructured":"Zavadil J et\u00a0al (2004) Integration of TGF-beta\/Smad and Jagged1\/notch signalling in epithelial-to-mesenchymal transition. EMBO J 23(5):1155\u20131165","journal-title":"EMBO J"},{"issue":"2","key":"3_CR141","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massague","year":"2008","unstructured":"Massague J (2008) TGFbeta in Cancer. Cell 134(2):215\u2013230","journal-title":"Cell"},{"issue":"2","key":"3_CR142","first-page":"381","volume":"143","author":"BI Dalal","year":"1993","unstructured":"Dalal BI, Keown PA, Greenberg AH (1993) Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am J Pathol 143(2):381\u2013389","journal-title":"Am J Pathol"},{"issue":"2A","key":"3_CR143","first-page":"721","volume":"28","author":"M Kawada","year":"2008","unstructured":"Kawada M et al (2008) Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I. Anticancer Res 28(2A):721\u2013730","journal-title":"Anticancer Res"},{"issue":"5","key":"3_CR144","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1091\/mbc.e02-09-0583","volume":"14","author":"RC Bates","year":"2003","unstructured":"Bates RC, Mercurio AM (2003) Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell 14(5):1790\u20131800","journal-title":"Mol Biol Cell"},{"issue":"5","key":"3_CR145","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ccr.2009.03.016","volume":"15","author":"Y Wu","year":"2009","unstructured":"Wu Y et al (2009) Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15(5):416\u2013428","journal-title":"Cancer Cell"},{"issue":"19","key":"3_CR146","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.1158\/0008-5472.CAN-04-1449","volume":"64","author":"J Wyckoff","year":"2004","unstructured":"Wyckoff J et\u00a0al (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64(19):7022\u20137029","journal-title":"Cancer Res"},{"issue":"12","key":"3_CR147","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra061808","volume":"355","author":"CT Jordan","year":"2006","unstructured":"Jordan CT, Guzman ML, Noble M (2006) Cancer stem cells. N Engl J Med 355(12):1253\u20131261","journal-title":"N Engl J Med"},{"issue":"19","key":"3_CR148","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"MF Clarke","year":"2006","unstructured":"Clarke MF et al (2006) Cancer stem cells--perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 66(19):9339\u20139344","journal-title":"Cancer Res"},{"key":"3_CR149","first-page":"1","volume-title":"Stem cell theory and inflammation-related cancer, in cancer and inflammation mechanisms : Chemical, biological, and clinical aspects","author":"T Tanno","year":"2014","unstructured":"Tanno T, Matsui W (2014) In: Hiraku YU, Kawanishi SO, Oshima H (eds) Stem cell theory and inflammation-related cancer, in cancer and inflammation mechanisms : Chemical, biological, and clinical aspects, p 1 online resource (409 pages)"},{"key":"3_CR150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2202-7-64","volume":"7","author":"D Widera","year":"2006","unstructured":"Widera D et al (2006) Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK\/NF-kappaB signaling. BMC Neurosci 7:64","journal-title":"BMC Neurosci"},{"issue":"4","key":"3_CR151","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1073\/pnas.98.4.1757","volume":"98","author":"J Audet","year":"2001","unstructured":"Audet J et\u00a0al (2001) Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells. Proc Natl Acad Sci U S A 98(4):1757\u20131762","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3_CR152","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cell.2007.01.003","volume":"128","author":"Z Tothova","year":"2007","unstructured":"Tothova Z et al (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128(2):325\u2013339","journal-title":"Cell"},{"issue":"1","key":"3_CR153","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4049\/jimmunol.178.1.103","volume":"178","author":"K Ito","year":"2007","unstructured":"Ito K et al (2007) Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes. J Immunol 178(1):103\u2013110","journal-title":"J Immunol"},{"issue":"4","key":"3_CR154","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm1388","volume":"12","author":"K Ito","year":"2006","unstructured":"Ito K et al (2006) Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12(4):446\u2013451","journal-title":"Nat Med"},{"issue":"1","key":"3_CR155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.stem.2008.11.006","volume":"4","author":"Y Liu","year":"2009","unstructured":"Liu Y et al (2009) p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 4(1):37\u201348","journal-title":"Cell Stem Cell"},{"issue":"19","key":"3_CR156","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1101\/gad.13.19.2478","volume":"13","author":"DM Adelman","year":"1999","unstructured":"Adelman DM, Maltepe E, Simon MC (1999) Multilineage embryonic hematopoiesis requires hypoxic ARNT activity. Genes Dev 13(19):2478\u20132483","journal-title":"Genes Dev"},{"issue":"10","key":"3_CR157","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrc2246","volume":"7","author":"RJ Gilbertson","year":"2007","unstructured":"Gilbertson RJ, Rich JN (2007) Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 7(10):733\u2013736","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"3_CR158","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2004-10-4135","volume":"105","author":"ML Guzman","year":"2005","unstructured":"Guzman ML et al (2005) The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105(11):4163\u20134169","journal-title":"Blood"},{"issue":"11","key":"3_CR159","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2174\/138161208784246225","volume":"14","author":"R Sullivan","year":"2008","unstructured":"Sullivan R, Graham CH (2008) Chemosensitization of cancer by nitric oxide. Curr Pharm Des 14(11):1113\u20131123","journal-title":"Curr Pharm Des"},{"issue":"Suppl 1","key":"3_CR160","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1677\/erc.1.01272","volume":"13","author":"E Tiligada","year":"2006","unstructured":"Tiligada E (2006) Chemotherapy: induction of stress responses. Endocr Relat Cancer 13(Suppl 1):S115\u2013S124","journal-title":"Endocr Relat Cancer"},{"issue":"16","key":"3_CR161","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.2174\/1381612043384411","volume":"10","author":"S Pervaiz","year":"2004","unstructured":"Pervaiz S, Clement MV (2004) Tumor intracellular redox status and drug resistance--serendipity or a causal relationship? Curr Pharm Des 10(16):1969\u20131977","journal-title":"Curr Pharm Des"},{"issue":"37","key":"3_CR162","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1038\/sj.onc.1208927","volume":"24","author":"J Zavadil","year":"2005","unstructured":"Zavadil J, Bottinger EP (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24(37):5764\u20135774","journal-title":"Oncogene"},{"issue":"12","key":"3_CR163","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1593\/neo.91084","volume":"11","author":"F Vesuna","year":"2009","unstructured":"Vesuna F et al (2009) Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 11(12):1318\u20131328","journal-title":"Neoplasia"},{"issue":"4","key":"3_CR164","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta PB et al (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138(4):645\u2013659","journal-title":"Cell"},{"issue":"4","key":"3_CR165","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704\u2013715","journal-title":"Cell"},{"issue":"56","key":"3_CR166","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1038\/sj.onc.1208990","volume":"24","author":"QD Nguyen","year":"2005","unstructured":"Nguyen QD et al (2005) Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the rho-rho kinase axis and tumor microenvironment. Oncogene 24(56):8240\u20138251","journal-title":"Oncogene"},{"issue":"3","key":"3_CR167","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ncb1691","volume":"10","author":"MH Yang","year":"2008","unstructured":"Yang MH et al (2008) Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10(3):295\u2013305","journal-title":"Nat Cell Biol"},{"issue":"12","key":"3_CR168","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1158\/1078-0432.CCR-09-2846","volume":"16","author":"AA Merchant","year":"2010","unstructured":"Merchant AA, Matsui W (2010) Targeting hedgehog--a cancer stem cell pathway. Clin Cancer Res 16(12):3130\u20133140","journal-title":"Clin Cancer Res"},{"issue":"7","key":"3_CR169","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","volume":"351","author":"CH Jamieson","year":"2004","unstructured":"Jamieson CH et al (2004) Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351(7):657\u2013667","journal-title":"N Engl J Med"}],"container-title":["Advances in Experimental Medicine and Biology","Cell &amp; Molecular Biology of Prostate Cancer"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-95693-0_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T06:45:40Z","timestamp":1537253140000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-95693-0_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319956923","9783319956930"],"references-count":169,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-95693-0_3","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}